Previous 10 | Next 10 |
2024-07-18 04:59:00 ET Some might hesitate to invest in stocks during a bull run, like the one we are experiencing. They argue that equities are likely to be overvalued. However, it's possible to find reasonably valued picks in this environment, even among top high-quality stocks. And some ...
2024-07-18 02:41:22 ET More on Novartis: Novartis Q2 Earnings Preview: Positive Fundamental Trends Should Continue Novartis: Buy This Blue-Chip Dividend Stock On Sale Now Novartis beats top-line and bottom-line estimates; raises FY24 core operating income out...
2024-07-18 01:48:21 ET More on Novartis: Novartis Q2 Earnings Preview: Positive Fundamental Trends Should Continue Novartis: Buy This Blue-Chip Dividend Stock On Sale Now Novartis intends to implement merger squeeze-out of MorphoSys minority shareholders Re...
2024-07-17 11:38:01 ET More on Novartis Novartis Q2 Earnings Preview: Positive Fundamental Trends Should Continue Novartis AG (NVS) Investor Event at ASCO Conference Call (Transcript) Novartis: Buy This Blue-Chip Dividend Stock On Sale Now Novartis intends to...
2024-07-17 11:20:00 ET Summary During the quarter, we sold our position in Novartis and invested the proceeds in Roche. We decided to sell Novartis to fund the purchase of what we believe is a more optimal investment in Roche. Considering Roche's ~4% dividend yield and our pro...
2024-07-17 11:05:00 ET Summary For the second quarter of 2024, Aristotle Capital’s International Equity Composite posted a total return of -0.85% gross of fees (-0.96% net of fees). During the quarter, we sold our position in Novartis and invested the proceeds in Roche. ...
2024-07-17 10:51:40 ET More on the markets Dow tops 41K, Nasdaq sinks 2%, S&P falls as well as rotation ramps up Dollar Crushed, Stocks Slump Fed Rate Cuts Imminent: 5 Things Dividend Investors Need To Know 3 Scenarios On How U.S. Markets May Perform For ...
2024-07-16 08:28:00 ET Summary The MSCI All Country World Index Net advanced 11.30% in the first half of 2024, one of its strongest performances since the late 1990s tech boom. Six "megacap" firms (Nvidia, Alphabet, Microsoft, Amazon, Meta, and Apple), benefiting from artificial i...
2024-07-15 10:09:03 ET Summary Novartis AG will report second quarter results this week. The company should report another strong quarter, with growth led by key products such as Entresto, Kesimpta, Kisqali, Cosentyx, and Leqvio. I expect a modest revenue and EPS beat, with NV...
2024-07-14 08:00:00 ET Earnings season kicks into high gear in mid-July, featuring a wave of releases from some of the world's most prominent companies. The docket includes major banks, pharmaceutical firms and airlines, as well as tech and telecom giants.... Read the full article on ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...